½ÃÀ庸°í¼­
»óǰÄÚµå
1472303

°ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : Á¦Ç° À¯Çüº°, ¼ÒÀ纰, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº° - ¼¼°è ±âȸ ºÐ¼®°ú »ê¾÷ ¿¹Ãø(2023-2032³â)

Intramedullary Nails Market By Product Type, By Material, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Allied Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 350 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±Ô¸ð´Â 2022³â¿¡ 17¾ï 890¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2023-2032³â¿¡ CAGR 5.6%·Î ¼ºÀåÇϸç, 2032³â¿¡´Â 10¾ï 3,200¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

Intramedullary Nails Market-IMG1

°ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀåÀ̶õ °ñ¼ö°­³» ±Ý¼ÓÁ¤ÀÇ Á¦Á¶, À¯Åë, ÆÇ¸Å¿Í °ü·ÃµÈ »ê¾÷À» ¸»ÇÕ´Ï´Ù. °ñ¼ö°­³» ±Ý¼ÓÁ¤Àº Á¤Çü¿Ü°ú¼ö¼ú¿¡¼­ Àå°ñ, ƯÈ÷ ´ëÅð°ñ, °æ°ñ, »ó¿Ï°ñÀÇ °ñÀýÀ» ¾ÈÁ¤È­Çϱâ À§ÇØ »ç¿ëµÇ´Â ÀÇ·á±â±¸ÀÔ´Ï´Ù. ÀϹÝÀûÀ¸·Î ½ºÅ×Àθ®½º°­, ƼŸ´½ ¹× ±âŸ Àç·á·Î ¸¸µé¾îÁö¸ç, »ÀÀÇ Ã´¼ö°ü¿¡ »ðÀԵǾî ȸº¹ °úÁ¤¿¡¼­ ±¸Á¶Àû Áö¿øÀ» Á¦°øÇÕ´Ï´Ù. °ñÀý °íÁ¤, º¯Çü ±³Á¤, °üÀý °íÁ¤ ¹× ±âŸ Á¢±Ù ¹æ½Ä¿¡ »ç¿ëµË´Ï´Ù. ÀÌ »ê¾÷¿¡´Â Á¤¹ÐÇÑ »À, Ư¼ö ȯÀÚ Áý´Ü, Ư¼ö ¼ö¼ú ÀýÂ÷¿¡ ¸Â°Ô ¼³°èµÈ °Í µî ´Ù¾çÇÑ À¯ÇüÀÇ °ñ¼ö°­³» ±Ý¼ÓÁ¤ÀÌ ÀÖ½À´Ï´Ù.

½ºÆ÷Ã÷ ¹× ·¹Å©¸®¿¡ÀÌ¼Ç È°µ¿ÀÇ ÀαⰡ ³ô¾ÆÁü¿¡ µû¶ó °ñÀýÀ» Æ÷ÇÔÇÑ ½ºÆ÷Ã÷ °ü·Ã ºÎ»óÀÇ ¹ß»ý·üÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ½ºÆ÷Ã÷ ¼±¼öµéÀº ´õ ºü¸¥ ȸº¹°ú Ȱµ¿ º¹±Í¸¦ ÃËÁøÇϱâ À§ÇØ °ñ¼ö³» ¸øÀ» »ç¿ëÇÏ´Â µî ¿Ü°úÀû °³ÀÔÀÌ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÇ·á ÀÎÇÁ¶ó, ƯÈ÷ ½ÅÈï ½ÃÀå¿¡¼­´Â Á¤Çü¿Ü°ú Ä¡·á¿Í ¼ö¼ú¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ È®´ë´Â Ä¡·á ´ë»ó ȯÀÚÃþÀ» È®´ëÇÔÀ¸·Î½á °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. Á¤Çü¿Ü°ú¼ö¼ú¿¡ ´ëÇÑ À¯¸®ÇÑ »óȯ Á¤Ã¥°ú º¸Çè Àû¿ëÀ¸·Î ȯÀÚµéÀº Å« °æÁ¦Àû ºÎ´ã ¾øÀÌ °ñ¼ö°­³» ±Ý¼ÓÁ¤ »ç¿ëÀ» Æ÷ÇÔÇÑ ÇÊ¿äÇÑ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±â¼ú ¹ßÀü, ³ëÀÎ Àα¸ Áõ°¡, ½ºÆ÷Ã÷ ¼Õ»óÀ¸·Î ÀÎÇÑ °ñÀý ¹ß»ý·ü Áõ°¡, ÃÖ¼Ò Ä§½À ¼ö¼ú Àü·«¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ µîÀÇ ¿äÀÎÀÌ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀåÀÇ ¼ºÀå°ú ¿ªÇп¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ºÒÃæºÐÇÑ »óȯÀ²°ú º¸Çè Àû¿ë Á¦ÇÑÀ¸·Î ÀÎÇØ ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿¡°Ô °æÁ¦Àû À庮ÀÌ ¹ß»ýÇÒ ¼ö ÀÖ½À´Ï´Ù. ƯÈ÷ ÀÇ·á ¿¹»êÀÌ Á¦ÇÑÀûÀÎ Áö¿ª¿¡¼­´Â »óȯ Á¦ÇÑÀ¸·Î ÀÎÇØ ½Ã¼ú Ƚ¼ö°¡ ÁÙ¾îµé¾î ½ÃÀå È®´ë¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÇ·á, ±³À°, ÀÚ¿ø¿¡ ´ëÇÑ Á¢±Ù¼º °ÝÂ÷¸¦ Æ÷ÇÔÇÑ »çȸ°æÁ¦Àû °ÝÂ÷´Â °ñ¼ö°­³» ±Ý¼ÓÁ¤°ú °°Àº Á¤Çü¿Ü°ú Ä¡·á ¼ö¿ä¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. Àú¼ÒµæÃþÀº °í±Þ Á¤Çü¿Ü°ú Ä¡·á¸¦ ¹Þ´Â µ¥ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖÀ¸¸ç, À̴ ƯÁ¤ Àα¸ Åë°è ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

»ç°í, ½ºÆ÷Ã÷ °ü·Ã »ç°Ç, ÀÚ¿¬ÀçÇØ·Î ÀÎÇÑ ¿Ü»ó ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó È¿°úÀûÀÎ ¿Ü»ó °ü¸® Àü·«ÀÇ Á߿伺ÀÌ ºÎ°¢µÇ°í ÀÖ½À´Ï´Ù. °ñÀýµÈ Àå°ñÀÇ ¾ÈÁ¤È­ ¹× Àç°Ç¿¡ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â °ñ¼ö°­³» ±Ý¼ÓÁ¤Àº ¿Ü»ó ºÐ¾ß¿¡¼­ ½ÃÀå ¼ºÀåÀÇ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Á¦Á¶¾÷üµéÀº ¿Ü»ó ¿Ü°úÀÇ»ç¿Í ÀÀ±ÞÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õÀÇ ÁøÈ­ÇÏ´Â ¿ä±¸¿¡ ºÎÀÀÇϱâ À§ÇØ Æ¯¼ö ¿Ü»ó¿ë ÀÓÇöõÆ®, ±â±¸ ¹× ¼ö¼ú ±â¹ýÀ» °³¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½ÀÀû ¼ö¼ú Á¢±Ù¹ýÀÌ ¼±È£µÊ¿¡ µû¶ó °ñ¼ö°­³» ±Ý¼ÓÁ¤ Á¦Á¶¾÷üµéÀº ÃÖ¼Òħ½ÀÀû ¼ö¼ú¿¡ ƯȭµÈ ÀÓÇöõÆ®¸¦ °³¹ß ¹× ÆÇ¸ÅÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¾ò°Ô µÇ¾ú½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼úÀÇ ÀÛÀº Àý°³Ã¢, Á¶Á÷ ¿Ü»ó °¨¼Ò, ȸº¹ ½Ã°£ ´ÜÃàÀº ȯÀÚ¿Í ¿Ü°úÀÇ»ç ¸ðµÎ¿¡°Ô ¾îÇÊÇÏ¿© ÀÌ·¯ÇÑ ¼ö¼úÀÇ Ã¤Åðú ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌÇØ°ü°èÀÚ ÁÖ¿ä ÀÌÁ¡

  • ÀÌ º¸°í¼­´Â 2022-2032³â °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ºÐ¼® ½ÃÀå ºÎ¹®, ÇöÀç µ¿Çâ, ÃßÁ¤ ¹× µ¿Çâ, ¿ªÇÐÀ» Á¤·®ÀûÀ¸·Î ºÐ¼®ÇÏ¿© ¿ì¼¼ÇÑ °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå ±âȸ¸¦ ½Äº°ÇÕ´Ï´Ù.
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ, ½ÃÀå ±âȸ¿Í °ü·ÃµÈ Á¤º¸¿Í ÇÔ²² ½ÃÀå Á¶»ç¸¦ Á¦°øÇÕ´Ï´Ù.
  • Porter's Five Forces ºÐ¼®Àº ÀÌÇØ °ü°èÀÚ°¡ ÀÌÀÍ Áß½ÉÀÇ ºñÁî´Ï½º °áÁ¤À» ³»¸®°í °ø±ÞÀÚ¿Í ±¸¸ÅÀÚÀÇ ³×Æ®¿öÅ©¸¦ °­È­ÇÒ ¼ö ÀÖµµ·Ï ±¸¸ÅÀÚ¿Í °ø±ÞÀÚÀÇ ÀáÀç·ÂÀ» ¹àÈü´Ï´Ù.
  • ³»Àå ¸ø ½ÃÀå ¼¼ºÐÈ­¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®À» ÅëÇØ ½ÃÀå ±âȸ¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • °¢ Áö¿ªÀÇ ÁÖ¿ä ±¹°¡´Â ¼¼°è ½ÃÀå¿¡ ´ëÇÑ ¸ÅÃ⠱⿩µµ¿¡ µû¶ó ¸ÅÇεǾî ÀÖ½À´Ï´Ù.
  • ½ÃÀå ±â¾÷ÀÇ Æ÷Áö¼Å´×Àº º¥Ä¡¸¶Å·À» ¿ëÀÌÇÏ°Ô ÇÏ°í ½ÃÀå ±â¾÷ÀÇ ÇöÀç À§Ä¡¸¦ ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­¿¡´Â Áö¿ªº° ¹× ¼¼°è °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå µ¿Çâ, ÁÖ¿ä ±â¾÷, ½ÃÀå ºÎ¹®, ¿ëµµ ¹× ½ÃÀå ¼ºÀå Àü·«¿¡ ´ëÇÑ ºÐ¼®ÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ °¡´ÉÇÑ º¸°í¼­ Ä¿½ºÅ͸¶ÀÌ¡

  • Á¦Ç°¿¡ Æ÷ÇÔµÈ ¿øÀç·á ºÐ¼®(%º°)
  • ÃÖÁ¾»ç¿ëÀÚ ¼±È£µµ ¹× ÆäÀÎ Æ÷ÀÎÆ®
  • ÅõÀÚ ±âȸ
  • Áö¿ªº° ½Å±Ô ÁøÃâ±â¾÷
  • ±â¼ú µ¿Ç⠺м®
  • À¯Åë¾÷ü ¸¶Áø ºÐ¼®
  • Á¦Ç°/ºÎ¹®º° ½ÃÀå ¼¼ºÐÈ­
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÅÁ¦Ç° °³¹ß/ Á¦Ç° ¸ÅÆ®¸¯½º
  • ±ÔÁ¦ °¡À̵å¶óÀÎ
  • °í°´ÀÇ °ü½É»ç¿¡ µû¸¥ Ãß°¡ ±â¾÷ °³¿ä
  • ºê·£µå Á¡À¯À² ºÐ¼®
  • ±â¾÷ °³¿ä È®Àå ¸®½ºÆ®
  • °ú°Å ½ÃÀå µ¥ÀÌÅÍ
  • ÁÖ¿ä ±â¾÷ÀÇ ¼¼ºÎ Á¤º¸(À§Ä¡, ¿¬¶ôó, °ø±Þ¾÷ü/º¥´õ ³×Æ®¿öÅ© µî Æ÷ÇÔ, ¿¢¼¿ Çü½Ä)
  • 1ÀÎ´ç ¼Òºñ µ¿Çâ
  • SWOT ºÐ¼®
  • ¼ö·® ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå °³¿ä

  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä Á¶»ç °á°ú
    • ¿µÇâ¿äÀÎ
    • ÁÖ¿ä ÅõÀÚ ±âȸ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¿ªÇÐ
    • ÃËÁø¿äÀÎ
    • ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • Æò±Õ ÆÇ¸Å °¡°Ý
  • ½ÃÀå Á¡À¯À² ºÐ¼®
  • ºê·£µå Á¡À¯À² ºÐ¼®
  • ¹«¿ª µ¥ÀÌÅÍ ºÐ¼®
  • Á¦Ç° ¼Òºñ
  • ¹ë·ùüÀÎ ºÐ¼®
  • ÁÖ¿ä ±ÔÁ¦ ºÐ¼®
  • ƯÇã »óȲ
  • ±ÔÁ¦ °¡À̵å¶óÀÎ
  • ÁÖ¿ä ±â¾÷ÀÇ »ó¼¼
  • »óȯ ½Ã³ª¸®¿À

Á¦4Àå °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : Á¦Ç° À¯Çüº°

  • °³¿ä
  • »óÁö°ñ
  • ÇÏÁö°ñ

Á¦5Àå °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : ¼ÒÀ纰

  • °³¿ä
  • ½ºÅ×Àθ®½º°­
  • ƼŸ´½

Á¦6Àå °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : ¿ëµµº°

  • °³¿ä
  • ´ëÅð°ñ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • °æ°ñ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • °¨¸¶ °ñ¼ö°­³» ±Ý¼ÓÁ¤
  • ±âŸ

Á¦7Àå °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ±âŸ

Á¦8Àå °ñ¼ö°­³» ±Ý¼ÓÁ¤ ½ÃÀå : Áö¿ªº°

  • °³¿ä
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ºê¶óÁú
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ¼­·Ð
  • ÁÖ¿ä ¼º°ø Àü·«
  • ÁÖ¿ä 10»çÀÇ Á¦Ç° ¸ÅÇÎ
  • °æÀï ´ë½Ãº¸µå
  • °æÀï È÷Æ®¸Ê
  • ÁÖ¿ä ±â¾÷ Æ÷Áö¼Å´×, 2022³â

Á¦10Àå ±â¾÷ °³¿ä

  • Stryker
  • B. Braun Melsungen AG
  • Zimmer Biomet
  • Smith+Nephew
  • Johnson & Johnson
  • Orthopaedic Implant Company
  • Orthofix Holdings, Inc.
  • Wright Medical Group N.V.
  • Advanced Orthopaedic Solutions
  • Aysam Ortopedi & Tibbi Cihazlar
KSA 24.05.14

The global intramedullary nail market is anticipated to reach $1,032.0 million by 2032, growing from $1,708.9 million in 2022 at a CAGR of 5.6% from 2023 to 2032.

Intramedullary Nails Market - IMG1

The intramedullary nail market refers to the industry involved in the manufacturing, distribution, and sale of intramedullary nails, which are medical gadgets used in orthopedic surgeries to stabilize fractures of lengthy bones, specifically in the femur, tibia, and humerus. Intramedullary nails are commonly made of materials like stainless steel or titanium and are inserted into the medullary canal of the bone to supply structural support during the recovery process. They are used in approaches such as fracture fixation, correction of deformities, and joint fusion. The industry encompasses a range of types of intramedullary nails, which include those designed for precise bones, unique patient populations, and specialized surgical techniques.

The growing popularity of sports and recreational activities has led to a higher incidence of sports-related injuries, including fractures. Athletes often require surgical intervention, including the use of intramedullary nails, to facilitate faster recovery and return to activity. Improvements in healthcare infrastructure, particularly in emerging markets, increase access to orthopedic care and surgical procedures. This expansion contributes to the growth of the intramedullary nail market by broadening the patient population receiving treatment. Favorable reimbursement policies and insurance coverage for orthopedic surgeries encourage patients to seek necessary treatment, including the use of intramedullary nails, without significant financial burden. Factors such as developments in technology, increasing incidence of fractures due to growing elderly populations and sports injuries, and rising demand for minimally invasive surgical strategies make a contribution to the growth and dynamics of the intramedullary nail market.

Inadequate reimbursement rates or restrictions on coverage for intramedullary nail procedures may create financial barriers for patients and healthcare providers. Limited reimbursement can reduce procedure volumes and hinder market expansion, particularly in regions with constrained healthcare budgets. Socioeconomic disparities, including disparities in access to healthcare, education, and resources, can influence the demand for orthopedic treatments such as intramedullary nails. Lower-income populations may face challenges in accessing advanced orthopedic care, affecting market growth in certain demographics.

The increasing incidence of traumatic injuries resulting from accidents, sports-related incidents, and natural disasters highlights the importance of effective trauma management strategies. Intramedullary nails are crucial in the stabilization and reconstruction of fractured long bones, providing opportunities for market growth in the trauma sector. Manufacturers can develop specialized trauma implants, instrumentation, and surgical techniques to address the evolving needs of trauma surgeons and emergency care providers. The growing preference for minimally invasive surgical approaches creates opportunities for intramedullary nail manufacturers to develop and market implants specifically designed for less invasive procedures. Smaller incisions, reduced tissue trauma, and faster recovery times associated with minimally invasive techniques appeal to both patients and surgeons, driving adoption of such techniques and market expansion.

The key players profiled in this report include Stryker, B. Braun Melsungen AG, Zimmer Biomet, Smith+Nephew, Johnson & Johnson, Orthopaedic Implant Company, Orthofix Holdings, Inc., Wright Medical Group N.V., Advanced Orthopaedic Solutions, and Aysam Ortopedi & Tibbi Cihazlar. The market players are continuously striving to achieve a dominant position in this competitive market using strategies such as collaborations and acquisitions.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intramedullary nails market analysis from 2022 to 2032 to identify the prevailing intramedullary nails market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intramedullary nails market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intramedullary nails market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Analysis of raw material in a product (by %)
  • End user preferences and pain points
  • Investment Opportunities
  • Upcoming/New Entrant by Regions
  • Technology Trend Analysis
  • Distributor margin Analysis
  • Market share analysis of players by products/segments
  • New Product Development/ Product Matrix of Key Players
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Brands Share Analysis
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Per Capita Consumption Trends
  • SWOT Analysis
  • Volume Market Size and Forecast

Key Market Segments

By Application

  • Femoral Intramedullary nail
  • Tibial Intramedullary Nail
  • Gamma Intramedullary Nail
  • Others

By End User

  • Hospitals
  • Specialty clinics
  • Others

By Product Type

  • Upper Bone Extremities
  • Lower Bone Extremities

By Material

  • Stainless Steel
  • Titanium

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • United Arab Emirates
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Stryker
    • B. Braun Melsungen AG
    • Zimmer Biomet
    • Smith+Nephew
    • Johnson & Johnson
    • Orthopaedic Implant Company
    • Orthofix Holdings, Inc.
    • Wright Medical Group N.V.
    • Advanced Orthopaedic Solutions
    • Aysam Ortopedi & Tibbi Cihazlar

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities
  • 3.5. Average Selling Price
  • 3.6. Market Share Analysis
  • 3.7. Brand Share Analysis
  • 3.8. Trade Data Analysis
  • 3.9. Product Consumption
  • 3.10. Value Chain Analysis
  • 3.11. Key Regulation Analysis
  • 3.12. Patent Landscape
  • 3.13. Regulatory Guidelines
  • 3.14. Key Players Details
  • 3.15. Reimbursement Scenario

CHAPTER 4: INTRAMEDULLARY NAILS MARKET, BY PRODUCT TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Upper Bone Extremities
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Lower Bone Extremities
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: INTRAMEDULLARY NAILS MARKET, BY MATERIAL

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Stainless Steel
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Titanium
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: INTRAMEDULLARY NAILS MARKET, BY APPLICATION

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Femoral Intramedullary nail
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Tibial Intramedullary Nail
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Gamma Intramedullary Nail
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country
  • 6.5. Others
    • 6.5.1. Key market trends, growth factors and opportunities
    • 6.5.2. Market size and forecast, by region
    • 6.5.3. Market share analysis by country

CHAPTER 7: INTRAMEDULLARY NAILS MARKET, BY END USER

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Hospitals
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Specialty clinics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Others
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: INTRAMEDULLARY NAILS MARKET, BY REGION

  • 8.1. Overview
    • 8.1.1. Market size and forecast By Region
  • 8.2. North America
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by Product Type
    • 8.2.3. Market size and forecast, by Material
    • 8.2.4. Market size and forecast, by Application
    • 8.2.5. Market size and forecast, by End User
    • 8.2.6. Market size and forecast, by country
      • 8.2.6.1. U.S.
      • 8.2.6.1.1. Market size and forecast, by Product Type
      • 8.2.6.1.2. Market size and forecast, by Material
      • 8.2.6.1.3. Market size and forecast, by Application
      • 8.2.6.1.4. Market size and forecast, by End User
      • 8.2.6.2. Canada
      • 8.2.6.2.1. Market size and forecast, by Product Type
      • 8.2.6.2.2. Market size and forecast, by Material
      • 8.2.6.2.3. Market size and forecast, by Application
      • 8.2.6.2.4. Market size and forecast, by End User
      • 8.2.6.3. Mexico
      • 8.2.6.3.1. Market size and forecast, by Product Type
      • 8.2.6.3.2. Market size and forecast, by Material
      • 8.2.6.3.3. Market size and forecast, by Application
      • 8.2.6.3.4. Market size and forecast, by End User
  • 8.3. Europe
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by Product Type
    • 8.3.3. Market size and forecast, by Material
    • 8.3.4. Market size and forecast, by Application
    • 8.3.5. Market size and forecast, by End User
    • 8.3.6. Market size and forecast, by country
      • 8.3.6.1. Germany
      • 8.3.6.1.1. Market size and forecast, by Product Type
      • 8.3.6.1.2. Market size and forecast, by Material
      • 8.3.6.1.3. Market size and forecast, by Application
      • 8.3.6.1.4. Market size and forecast, by End User
      • 8.3.6.2. UK
      • 8.3.6.2.1. Market size and forecast, by Product Type
      • 8.3.6.2.2. Market size and forecast, by Material
      • 8.3.6.2.3. Market size and forecast, by Application
      • 8.3.6.2.4. Market size and forecast, by End User
      • 8.3.6.3. France
      • 8.3.6.3.1. Market size and forecast, by Product Type
      • 8.3.6.3.2. Market size and forecast, by Material
      • 8.3.6.3.3. Market size and forecast, by Application
      • 8.3.6.3.4. Market size and forecast, by End User
      • 8.3.6.4. Spain
      • 8.3.6.4.1. Market size and forecast, by Product Type
      • 8.3.6.4.2. Market size and forecast, by Material
      • 8.3.6.4.3. Market size and forecast, by Application
      • 8.3.6.4.4. Market size and forecast, by End User
      • 8.3.6.5. Italy
      • 8.3.6.5.1. Market size and forecast, by Product Type
      • 8.3.6.5.2. Market size and forecast, by Material
      • 8.3.6.5.3. Market size and forecast, by Application
      • 8.3.6.5.4. Market size and forecast, by End User
      • 8.3.6.6. Rest of Europe
      • 8.3.6.6.1. Market size and forecast, by Product Type
      • 8.3.6.6.2. Market size and forecast, by Material
      • 8.3.6.6.3. Market size and forecast, by Application
      • 8.3.6.6.4. Market size and forecast, by End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by Product Type
    • 8.4.3. Market size and forecast, by Material
    • 8.4.4. Market size and forecast, by Application
    • 8.4.5. Market size and forecast, by End User
    • 8.4.6. Market size and forecast, by country
      • 8.4.6.1. China
      • 8.4.6.1.1. Market size and forecast, by Product Type
      • 8.4.6.1.2. Market size and forecast, by Material
      • 8.4.6.1.3. Market size and forecast, by Application
      • 8.4.6.1.4. Market size and forecast, by End User
      • 8.4.6.2. Japan
      • 8.4.6.2.1. Market size and forecast, by Product Type
      • 8.4.6.2.2. Market size and forecast, by Material
      • 8.4.6.2.3. Market size and forecast, by Application
      • 8.4.6.2.4. Market size and forecast, by End User
      • 8.4.6.3. India
      • 8.4.6.3.1. Market size and forecast, by Product Type
      • 8.4.6.3.2. Market size and forecast, by Material
      • 8.4.6.3.3. Market size and forecast, by Application
      • 8.4.6.3.4. Market size and forecast, by End User
      • 8.4.6.4. South Korea
      • 8.4.6.4.1. Market size and forecast, by Product Type
      • 8.4.6.4.2. Market size and forecast, by Material
      • 8.4.6.4.3. Market size and forecast, by Application
      • 8.4.6.4.4. Market size and forecast, by End User
      • 8.4.6.5. Australia
      • 8.4.6.5.1. Market size and forecast, by Product Type
      • 8.4.6.5.2. Market size and forecast, by Material
      • 8.4.6.5.3. Market size and forecast, by Application
      • 8.4.6.5.4. Market size and forecast, by End User
      • 8.4.6.6. Rest of Asia-Pacific
      • 8.4.6.6.1. Market size and forecast, by Product Type
      • 8.4.6.6.2. Market size and forecast, by Material
      • 8.4.6.6.3. Market size and forecast, by Application
      • 8.4.6.6.4. Market size and forecast, by End User
  • 8.5. LAMEA
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by Product Type
    • 8.5.3. Market size and forecast, by Material
    • 8.5.4. Market size and forecast, by Application
    • 8.5.5. Market size and forecast, by End User
    • 8.5.6. Market size and forecast, by country
      • 8.5.6.1. Brazil
      • 8.5.6.1.1. Market size and forecast, by Product Type
      • 8.5.6.1.2. Market size and forecast, by Material
      • 8.5.6.1.3. Market size and forecast, by Application
      • 8.5.6.1.4. Market size and forecast, by End User
      • 8.5.6.2. Saudi Arabia
      • 8.5.6.2.1. Market size and forecast, by Product Type
      • 8.5.6.2.2. Market size and forecast, by Material
      • 8.5.6.2.3. Market size and forecast, by Application
      • 8.5.6.2.4. Market size and forecast, by End User
      • 8.5.6.3. United Arab Emirates
      • 8.5.6.3.1. Market size and forecast, by Product Type
      • 8.5.6.3.2. Market size and forecast, by Material
      • 8.5.6.3.3. Market size and forecast, by Application
      • 8.5.6.3.4. Market size and forecast, by End User
      • 8.5.6.4. South Africa
      • 8.5.6.4.1. Market size and forecast, by Product Type
      • 8.5.6.4.2. Market size and forecast, by Material
      • 8.5.6.4.3. Market size and forecast, by Application
      • 8.5.6.4.4. Market size and forecast, by End User
      • 8.5.6.5. Rest of LAMEA
      • 8.5.6.5.1. Market size and forecast, by Product Type
      • 8.5.6.5.2. Market size and forecast, by Material
      • 8.5.6.5.3. Market size and forecast, by Application
      • 8.5.6.5.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top winning strategies
  • 9.3. Product mapping of top 10 player
  • 9.4. Competitive dashboard
  • 9.5. Competitive heatmap
  • 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

  • 10.1. Stryker
    • 10.1.1. Company overview
    • 10.1.2. Key executives
    • 10.1.3. Company snapshot
    • 10.1.4. Operating business segments
    • 10.1.5. Product portfolio
    • 10.1.6. Business performance
    • 10.1.7. Key strategic moves and developments
  • 10.2. B. Braun Melsungen AG
    • 10.2.1. Company overview
    • 10.2.2. Key executives
    • 10.2.3. Company snapshot
    • 10.2.4. Operating business segments
    • 10.2.5. Product portfolio
    • 10.2.6. Business performance
    • 10.2.7. Key strategic moves and developments
  • 10.3. Zimmer Biomet
    • 10.3.1. Company overview
    • 10.3.2. Key executives
    • 10.3.3. Company snapshot
    • 10.3.4. Operating business segments
    • 10.3.5. Product portfolio
    • 10.3.6. Business performance
    • 10.3.7. Key strategic moves and developments
  • 10.4. Smith+Nephew
    • 10.4.1. Company overview
    • 10.4.2. Key executives
    • 10.4.3. Company snapshot
    • 10.4.4. Operating business segments
    • 10.4.5. Product portfolio
    • 10.4.6. Business performance
    • 10.4.7. Key strategic moves and developments
  • 10.5. Johnson & Johnson
    • 10.5.1. Company overview
    • 10.5.2. Key executives
    • 10.5.3. Company snapshot
    • 10.5.4. Operating business segments
    • 10.5.5. Product portfolio
    • 10.5.6. Business performance
    • 10.5.7. Key strategic moves and developments
  • 10.6. Orthopaedic Implant Company
    • 10.6.1. Company overview
    • 10.6.2. Key executives
    • 10.6.3. Company snapshot
    • 10.6.4. Operating business segments
    • 10.6.5. Product portfolio
    • 10.6.6. Business performance
    • 10.6.7. Key strategic moves and developments
  • 10.7. Orthofix Holdings, Inc.
    • 10.7.1. Company overview
    • 10.7.2. Key executives
    • 10.7.3. Company snapshot
    • 10.7.4. Operating business segments
    • 10.7.5. Product portfolio
    • 10.7.6. Business performance
    • 10.7.7. Key strategic moves and developments
  • 10.8. Wright Medical Group N.V.
    • 10.8.1. Company overview
    • 10.8.2. Key executives
    • 10.8.3. Company snapshot
    • 10.8.4. Operating business segments
    • 10.8.5. Product portfolio
    • 10.8.6. Business performance
    • 10.8.7. Key strategic moves and developments
  • 10.9. Advanced Orthopaedic Solutions
    • 10.9.1. Company overview
    • 10.9.2. Key executives
    • 10.9.3. Company snapshot
    • 10.9.4. Operating business segments
    • 10.9.5. Product portfolio
    • 10.9.6. Business performance
    • 10.9.7. Key strategic moves and developments
  • 10.10. Aysam Ortopedi & Tibbi Cihazlar
    • 10.10.1. Company overview
    • 10.10.2. Key executives
    • 10.10.3. Company snapshot
    • 10.10.4. Operating business segments
    • 10.10.5. Product portfolio
    • 10.10.6. Business performance
    • 10.10.7. Key strategic moves and developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦